ADIPOQ and obesity disorder: Borst et al. have shown that in the context of obesity, visceral fat derived resistin, TNF-α and several other interleukins contribute to insulin resistance [35], whereas weight loss or visceral fat removal decrease serum IL-6 and increase the insulin sensitizing hormone adiponectin [34, 35].